Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 132

1.

Traffic Light: prognosis-based eligibility for clinical trials of hematopoietic SCT in adults with sickle cell anemia.

Rotz SJ, O'Riordan MA, Kim C, de Lima M, Gladwin MT, Little JA.

Bone Marrow Transplant. 2015 Mar 16. doi: 10.1038/bmt.2015.11. [Epub ahead of print]

PMID:
25774596
2.

Non-invasive estimation of pulmonary artery pressures in patients with sickle cell anaemia in Ibadan, Nigeria: an echocardiographic study.

Enakpene EO, Adebiyi AA, Ogah OS, Olaniyi JA, Aje A, Adeoye MA, Falase AO.

Acta Cardiol. 2014 Oct;69(5):505-11.

PMID:
25638838
3.

[Chronic complications of sickle cell disease].

Bartolucci P, Lionnet F.

Rev Prat. 2014 Oct;64(8):1120-6. French.

PMID:
25510140
4.

MicroRNA 648 Targets ET-1 mRNA and is cotranscriptionally regulated with MICAL3 by PAX5.

Li C, Gonsalves CS, Eiymo Mwa Mpollo MS, Malik P, Tahara SM, Kalra VK.

Mol Cell Biol. 2015 Feb;35(3):514-28. doi: 10.1128/MCB.01199-14. Epub 2014 Nov 17.

PMID:
25403488
5.

An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease.

Klings ES, Machado RF, Barst RJ, Morris CR, Mubarak KK, Gordeuk VR, Kato GJ, Ataga KI, Gibbs JS, Castro O, Rosenzweig EB, Sood N, Hsu L, Wilson KC, Telen MJ, Decastro LM, Krishnamurti L, Steinberg MH, Badesch DB, Gladwin MT; American Thoracic Society Ad Hoc Committee on Pulmonary Hypertension of Sickle Cell Disease.

Am J Respir Crit Care Med. 2014 Mar 15;189(6):727-40. doi: 10.1164/rccm.201401-0065ST.

6.

Alterations of the arginine metabolome in sickle cell disease: a growing rationale for arginine therapy.

Morris CR.

Hematol Oncol Clin North Am. 2014 Apr;28(2):301-21. doi: 10.1016/j.hoc.2013.11.008. Review.

PMID:
24589268
7.

Hypoxic response contributes to altered gene expression and precapillary pulmonary hypertension in patients with sickle cell disease.

Zhang X, Zhang W, Ma SF, Desai AA, Saraf S, Miasniakova G, Sergueeva A, Ammosova T, Xu M, Nekhai S, Abbasi T, Casanova NG, Steinberg MH, Baldwin CT, Sebastiani P, Prchal JT, Kittles R, Garcia JG, Machado RF, Gordeuk VR.

Circulation. 2014 Apr 22;129(16):1650-8. doi: 10.1161/CIRCULATIONAHA.113.005296. Epub 2014 Feb 10.

8.

Factors associated with survival in a contemporary adult sickle cell disease cohort.

Elmariah H, Garrett ME, De Castro LM, Jonassaint JC, Ataga KI, Eckman JR, Ashley-Koch AE, Telen MJ.

Am J Hematol. 2014 May;89(5):530-5. doi: 10.1002/ajh.23683. Epub 2014 Feb 21.

PMID:
24478166
9.

Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell disease.

Cho G, Hambleton IR.

Cochrane Database Syst Rev. 2014 Jan 8;1:CD008360. doi: 10.1002/14651858.CD008360.pub3. Review.

PMID:
24399756
10.

[Cardiopulmonary complications in sickle cell anemia].

Rojas-Jiménez S, Lopera-Valle J, Yabur-Espítia M.

Arch Cardiol Mex. 2013 Oct-Dec;83(4):289-94. doi: 10.1016/j.acmx.2013.05.003. Epub 2013 Nov 9. Spanish.

PMID:
24215682
11.

Prevalence of pulmonary arterial hypertension among sickle cell disease patients in Al Hassa.

Al-Khoufi EA.

Glob J Health Sci. 2013 Jun 30;5(5):174-80. doi: 10.5539/gjhs.v5n5p174.

12.

Longitudinal study of echocardiography-derived tricuspid regurgitant jet velocity in sickle cell disease.

Desai PC, May RC, Jones SK, Strayhorn D, Caughey M, Hinderliter A, Ataga KI.

Br J Haematol. 2013 Sep;162(6):836-41. doi: 10.1111/bjh.12453. Epub 2013 Jul 6.

13.

The association between tricuspid regurgitation velocity and 5-year survival in a North West London population of patients with sickle cell disease in the United Kingdom.

Cabrita IZ, Mohammed A, Layton M, Ghorashian S, Gilmore A, Cho G, Howard J, Anie KA, Desforges L, Bassett P, Grapsa J, Howard L, Mahalingam G, Dawson D, Pinto FJ, Nihoyannopoulos P, Davies SC, Gibbs JS.

Br J Haematol. 2013 Aug;162(3):400-8. doi: 10.1111/bjh.12391. Epub 2013 May 29.

PMID:
23713628
14.

Prolongation of QTc intervals and risk of death among patients with sickle cell disease.

Upadhya B, Ntim W, Brandon Stacey R, Henderson R, Leedy D, O'Brien FX, Knovich MA.

Eur J Haematol. 2013 Aug;91(2):170-8. doi: 10.1111/ejh.12127. Epub 2013 Jun 28.

PMID:
23621844
15.

Asymmetric dimethylarginine levels in children with sickle cell disease and its correlation to tricuspid regurgitant jet velocity.

El-Shanshory M, Badraia I, Donia A, Abd El-Hameed F, Mabrouk M.

Eur J Haematol. 2013 Jul;91(1):55-61. doi: 10.1111/ejh.12114. Epub 2013 May 3.

PMID:
23551575
16.

Long-term outcome and evaluation of organ function in pediatric patients undergoing haploidentical and matched related hematopoietic cell transplantation for sickle cell disease.

Dallas MH, Triplett B, Shook DR, Hartford C, Srinivasan A, Laver J, Ware R, Leung W.

Biol Blood Marrow Transplant. 2013 May;19(5):820-30. doi: 10.1016/j.bbmt.2013.02.010. Epub 2013 Feb 14.

PMID:
23416852
17.

Hemodynamic predictors of mortality in adults with sickle cell disease.

Mehari A, Alam S, Tian X, Cuttica MJ, Barnett CF, Miles G, Xu D, Seamon C, Adams-Graves P, Castro OL, Minniti CP, Sachdev V, Taylor JG 6th, Kato GJ, Machado RF.

Am J Respir Crit Care Med. 2013 Apr 15;187(8):840-7. doi: 10.1164/rccm.201207-1222OC.

18.

Tissue Doppler echocardiographic findings of left ventricle in children with sickle-cell anemia.

Ghaderian M, Keikhaei B, Heidari M, Salehi Z, Azizi Malamiri R.

J Tehran Heart Cent. 2012 Aug;7(3):106-10. Epub 2012 Aug 31.

19.

The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe.

Nouraie M, Lee JS, Zhang Y, Kanias T, Zhao X, Xiong Z, Oriss TB, Zeng Q, Kato GJ, Gibbs JS, Hildesheim ME, Sachdev V, Barst RJ, Machado RF, Hassell KL, Little JA, Schraufnagel DE, Krishnamurti L, Novelli E, Girgis RE, Morris CR, Rosenzweig EB, Badesch DB, Lanzkron S, Castro OL, Goldsmith JC, Gordeuk VR, Gladwin MT; Walk-PHASST Investigators and Patients.

Haematologica. 2013 Mar;98(3):464-72. doi: 10.3324/haematol.2012.068965. Epub 2012 Sep 14.

20.

A novel molecular signature for elevated tricuspid regurgitation velocity in sickle cell disease.

Desai AA, Zhou T, Ahmad H, Zhang W, Mu W, Trevino S, Wade MS, Raghavachari N, Kato GJ, Peters-Lawrence MH, Thiruvoipati T, Turner K, Artz N, Huang Y, Patel AR, Yuan JX, Gordeuk VR, Lang RM, Garcia JG, Machado RF.

Am J Respir Crit Care Med. 2012 Aug 15;186(4):359-68. doi: 10.1164/rccm.201201-0057OC. Epub 2012 Jun 7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk